Tagcloud

ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome

MIMS Ireland: May 2008

Second phase III study of Avastin

01 May 2008 | New Clinical Evidence

Second phase III study of Avastin in 1st line metastatic breast cancer meets its primary endpoint - Roche has recently announced that a phase III study in metastatic breast cancer investigating Avastin (bevacizumab) in combination with docetaxel chemotherapy compared to... Read more

New review highlights Femara benefits

01 May 2008 | New Clinical Evidence

New review highlights Femara benefits in terms of reduction of the risk of distant relapse in women with hormone-sensitive breast cancer - A new review underlining the significance of distant metastases in breast cancer outcomes highlights the benefits of aromatase... Read more

Seroquel XR once-daily prolonged tablets

01 May 2008 | New Clinical Evidence

Seroquel XR once-daily prolonged tablets for the treatment of schizophrenia - AstraZeneca announced last month the Irish launch of Seroquel XR (quetiapine fumarate) Prolonged-Release Tablets, a once-daily medicine for the treatment of schizophrenia in adult patients.... Read more

Nilotinib Is Highly Active and Safe

01 May 2008 | New Clinical Evidence

Nilotinib Is Highly Active and Safe in Chronic Myelogenous Leukaemia Patients with Imatinib-Resistance or Intolerance - New data demonstrated the efficacy and tolerability of Tasigna (nilotinib) in the treatment of Chronic myelogenous leukaemia (CML) patients with Imatinib-Resistance or Intolerance for... Read more

Zevalin Receives Positive CHMP Opinion

01 May 2008 | New Clinical Evidence

Zevalin Receives Positive CHMP Opinion in Europe for First-Line Consolidation Treatment - Bayer Schering Pharma AG has received a positive opinion from the European Committee for Medicinal Products for Human Use (CHMP) recommending Zevalin ([90Y]-ibritumomab tiuxetan) as consolidation therapy after... Read more

MIMS Ireland - Change in Pricing Policy

01 May 2008 | New this Month

Following changes introduced by the HSE for the reimbursement of medicines under the various HSE community schemes, and as MIMS Ireland relies on manufacturers for the prices published with entries, the pricing policy of MIMS Ireland has changed. From May... Read more

Ixprim

01 May 2008 | New Products

Company: Grünenthal Pharma Ltd. Legal category: Prescription. GMS (from May 6th). Sport permitted. Active ingredient: Tramadol hydrochloride 37.5mg, paracetamol 325mg Description: Pale yellow film coated-tablets. Presentation: 60, €13.20. Indications: Treatment of moderate to severe pain requiring a combination of tramadol... Read more

Retacrit

01 May 2008 | New Products

Company: Hospira Ireland Ltd. Legal category: Prescription. Sport prohibited. Active ingredient: Epoetin zeta (recombinant human erythropoietin) 3333 IU/ml, 10000 IU/ml, 40000 IU/ml. Description: Clear, colourless solution for injection in pre-filled syringe. Presentation: 1000 IU/0.3ml-6, €54.59; 2000 IU/0.6ml-6, €104.82; 3000 IU/0.9ml-6,... Read more

Tasigna

01 May 2008 | New Products

Company: Novartis Ireland Ltd. Legal category: Prescription. Sport permitted. Active ingredient: Nilotinib 200mg (as hydrochloride monohydrate). Description: White to slightly yellowish powder in light yellow opaque hard gelatine capsules, size 0 with red axial imprint NVR/TKI. Presentation: 112, price available... Read more

Trimoptin

01 May 2008 | New Products

Company: Athlone Laboratories Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Trimethoprim 200mg Description: Flat, white, bevelled-edge tablets embossed TR 200. Presentation: 100, €12.20. Indications: Treatment of infections caused by susceptible organisms including most gram-positive and gram-negative aerobic organisms... Read more

Versiva XC

01 May 2008 | New Products

Company: ConvaTec Ireland. Description: Sterile gelling foam dressing consisting of a top polyurethane foam/film layer, a non-woven fibrous hydrofibre layer, and a thin non-adhesive layer or adhesive border. Presentation: Non-Adhesive: 7.5cm x 7.5cm-10, €20.70; 11cm x 11cm-10, €34.50; 15cm x... Read more

Rispone 6mg tablets

01 May 2008 | New Presentations

Company: Rowex Ltd. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Risperidone 6mg Description: Yellow oval film-coated tablet with two breaking notches on either side. The tablet can be divided into thirds. Presentation: 28, €135.38. Indications: Treatment of schizophrenia. Maintenance... Read more

New indication for Pemetrexed (Alimta) in combination with cisplatin

01 May 2008 | New this Month

Pemetrexed (Alimta) in combination with cisplatin is now indicated for the 1st line treatment of stage 3B / 4 non small cell lung cancer (NSCLC), other than predominantly squamous cell histology.... Read more

Hospira launches Octreotide solution for injection

01 May 2008 | New this Month

Hospira Ireland Ltd is pleased to announce the launch of Octreotide, the first alternative to Sandostatin available in this market. Octreotide is available in a wide range of presentations: 0.05mg/ml, 0.1mg/ml, 0.2mg/ml, and 0.5mg/ml vials, offering choice, flexibility and convenience.... Read more

Innohep 10 pack launch

01 May 2008 | New this Month

LEO Pharma wishes to announce that the following Innohep syringes have become available in packs of 10 from 1st April 2008: Innohep -10,000 IU in 0.5ml solution for injection, Innohep -14,000 IU in 0.7ml solution for injection and Innohep -18,000... Read more

Andropatch discontinued

01 May 2008 |

GlaxoSmithKline wishes to announce that Andropatch (testosterone) 2.5mg transdermal patch has been discontinued since January 28th 2008. Alternative testosterone treatments are available on the market as replacement therapies for male hypogonadism. GlaxoSmithKline apologises for any inconvenience caused. Please call (01)... Read more

Apo Go 20mg/2ml discontinuation

01 May 2008 | Discontinued Products

Clonmel Healthcare Ltd wishes to inform you that Apo Go 20mg/2ml has been discontinued. Apo Go 50mg/5ml remains on the market. Should you have any queries, please do not hesitate to contact Clonmel Healthcare Ltd at (01) 620 4000.... Read more

Discontinuation of Feldene Topigel

01 May 2008 | Discontinued Products

Pfizer wishes to inform you that as a result of a change in the production facility for Feldene Topigel 30g OTC, this product was discontinued on 31st March 2008. There are no changes relating to Feldene gel 60g presentation. Should... Read more

Discontinuation of Mexitil ampoules and capsules

01 May 2008 | Discontinued Products

Boehringer Ingelheim wishes to announce that Mexitil (mexiletine hydrocholoride) ampoules (25mg/ml), Mexitil capsules (50mg) and Mexitil capsules (200mg) are being discontinued on June 30th 2008. We therefore recommend that you now consider suitable therapeutic alternatives for your patients currently receiving... Read more

Discontinuation of Rocaltrol 0.5mcg capsules

01 May 2008 | Discontinued Products

As part of a regular review of products in its pharmaceutical portfolio, Roche Products (Ireland) Ltd wish to inform you of the discontinuation of one of its products, Rocaltrol 0.5mcg capsules. Due to low demand for the Rocaltrol 0.5mcg presentation,... Read more

Discontinuation of Symmetrel 100mg capsules

01 May 2008 | Discontinued Products

Novartis Ireland Ltd announces the discontinuation of Symmetrel 100mg capsules (amantadine hydrochloride) from May 30th 2008 due to cessation of production at the registered manufacturing site. Please be informed that alternative medicines are available for patients in this category. For... Read more